Results 201 to 210 of about 8,834,434 (252)

Ovarian pain in the mare: Clinical implications of mittelschmerz and oestrus‐related behavioural abnormalities

Equine Veterinary Education, Volume 38, Issue 12, Page 661-667, December 2026.
Summary Mittelschmerz is a well‐recognised benign peri‐ovulatory pain syndrome in women and, by physiological analogy, may also occur in mares. In equine practice, peri‐ovulatory ovarian pain has been associated with transient discomfort, colic‐like signs and behavioural changes, although its true clinical relevance remains poorly defined.
G. Marino, V. Biondi, A. Sfacteria, G. Catone, C. Vullo   +4 more
wiley   +1 more source

Harnessing telemedicine to deliver patient-centered opioid agonist treatment within a community-based harm reduction service: a mixed methods evaluation. [PDF]

Harm Reduct J
Høj SB, Coignard-Friedman R, Sako A, de Montigny C, Beauchemin-Nadeau MÈ, Léandre R, Minoyan N, Boyer-Legault G, Chougar S, Lamont SK, Bruneau J.   +10 more
europepmc   +1 more source

Swiss Practice Recommendations for Chronic Prurigo Including Prurigo Nodularis

International Journal of Dermatology, Volume 65, Issue 12, Page 2497-2508, December 2026.
Chronic prurigo, including prurigo nodularis, is a chronic, often treatment‐refractory condition characterized by persistent pruritus and chronic scratch lesions. Advances in the understanding of its underlying pathophysiology have enabled the development of novel targeted therapies; however, management remains challenging due to the expanding range of
Simon M. Mueller, Helmut Beltraminelli, Wolf‐Henning Boehncke, Maximilian Böhm, Antonio Cozzio, Peter Häusermann, Ahmad Jalili, Antonios G. A. Kolios, Claudia Lang, Eva Loos, Christoph Schlapbach, Curdin Conrad   +11 more
wiley   +1 more source

Challenges for the implementation of injectable opioid agonist treatment: a scoping review. [PDF]

Harm Reduct J
Schwarz T, Akartuna D, Busch M, Krausz RM, Uhl A.   +4 more
europepmc   +1 more source

Increasing HCV Diagnosis and Treatment Uptake Among Community‐Recruited People Who Inject Drugs in Athens, Greece, During the Transition to Unrestricted Access to Direct‐Acting Antivirals

Journal of Viral Hepatitis, Volume 33, Issue 12, December 2026.
ABSTRACT Eliminating hepatitis C requires focusing efforts on people who inject drugs (PWID). The ARISTOTLE HCV‐HIV program aimed to increase HCV and HIV diagnosis and linkage to care among PWID, particularly those currently injecting and not linked to opioid agonist treatment (OAT).
Sotirios Roussos, Georgios Papatheodoridis, Theodoros Angelopoulos, Evangelos Cholongitas, Nikolaos Papadopoulos, Spyridon Savvanis, Athina Chounta, Fani Pliarchopoulou, Panagiota Ioannidou, Melanie Deutsch, Maria‐Vasiliki Papageorgiou, Spilios Manolakopoulos, Vasileios Sevastianos, Andreas Kapatais, Ioannis Vlachogiannakos, Maria Mela, Ioannis Elefsiniotis, Spyridon Vrakas, Dimitrios S. Karagiannakis, Savvas Chaikalis, Dimitrios Paraskevis, Mina Psichogiou, George Kalamitsis, Angelos Hatzakis, Vana Sypsa   +24 more
wiley   +1 more source

Beyond Nature's Blueprint: Macrocyclic Peptides Containing Unnatural Amino Acids in Therapeutic Development

Angewandte Chemie, Volume 138, Issue 45, 2 November 2026.
Strategic incorporation of unnatural amino acids transforms macrocyclic peptides into drug‐like molecules capable of engaging challenging targets. These building blocks enhance stability, permeability, and bioavailability, accelerating the development of next‐generation peptide therapeutics.
Krishna K. Sharma, Komal Sharma, Anku Sharma, Kamya Rao, Rahul Jain, Brett VanVeller   +5 more
wiley   +2 more sources

Gender differences regarding interest in opioid agonist treatment with hydromorphone: a cross-sectional study of syringe service program participants. [PDF]

Harm Reduct J
Lasiychuk V, Ghiroli M, López-Castro T, Fox AD.   +3 more
europepmc   +1 more source

Reductions in Advanced Chronic Liver Disease Among People Who Inject Drugs: The ETHOS Engage Study

Liver International, Volume 46, Issue 12, December 2026.
ABSTRACT Background and Aims Liver disease is a significant risk for people who inject drugs due to the high burden of hepatitis C virus (HCV). There is limited data on the impact of the direct‐acting antiviral (DAA) therapy era on liver disease among people who inject drugs.
Anna Conway, Heather Valerio, Jessie Payne, David Silk, Alison D. Marshall, Marianne Martinello, Shane Tillakeratne, Putu Novi Arfirsta Dharmayani, Andrew Milat, Janaki Amin, Phillip Read, Louisa Degenhardt, Annabelle Stevens, Jeremy Hayllar, Michael Christmass, Victoria Cock, Jessica Doumany, Jason Grebely, Gregory J. Dore, on behalf of the ETHOS Engage Study Group, Amanda Erratt, Kyle Leadbeatter, Carla Treloar, Adrian Dunlop, Carolyn Murray, Mary Ellen Harrod, Mel Rhagnath, Clarke Scott, Vicky Cock, Jess Doumany, Dominic Mounsey, Maria Martinez, Amanda Erratt, Nadine Ezard, Craig Rodgers, David Reid, Carla Gorton, Jeremy Hayllar, Thao Lam, Adrian Dunlop, Prasun Datta, Alex Wade, Sally Spruce, Vicki Cock, Sarah Michelmore, Mark Cornwell, Krista Zohrab, Kate Salisbury, Patricia Collie, Craig Connelly, Angela Cooper, Mark Montebello, Chris Gough, Robert Cherry, Julie Dyer, Shikha Agrawal, Elke Press, Alice Wang, Teodora Zanesheva‐Karamanlieva, Eleanor Kessler, Nadine Horasak, Rhondda Lewis, Astrid Carthew, Daniel Morris, Kathy Donohue, Faith Bassett, Kathy Griffiths, Jason Dalla Lana, Sue Shin, Kylie Page, Julie Luff, Rebecca Hyland, Jane Booty, Todd McKillop, Connie Graf, Adele Hampson, Siyu Qian, Danielle Brown, Amber Lautier, Cate Curran, Peta McAlister, Peter Warburton, Rachel Pollard, Daniel Pekin‐Stores, Jessica Rees, Danielle Gaudiosi, Tammy Raikko, Martina Camitz, Corrie Brandsma‐McGrath, Emma Harkins, Nicole Stuart, Coby‐Lea Chalker, Carly Harvey, Edwin Christopher, David Khalil, Kerry McMorrow, Melissa Wellman, Carina Burns, Ravina Raidu, Kylie Stolzenhein, Wanda Brabender, Kelly Somes, Gary Keogh, Isabella Conwell, Nargis Abram, Rick Turner, Stuart Larter, Fiona Goodberg, Jennifer Luksza, Meryem Jefferies, Michelle Hall, Susan Hazelwood, Charlotte Ismay, Antoni Pazeski, Bettina Sweetman, Michelle Gallagher, Cecily Willis, Amanda Brown, Belinda McClurg, Cherie Mincham, Kali Barlow, Anita Hoskins, Laura Johnson, Courtney Priestley, Amie Johns, Shane Moore, Kerrie‐Ann Lahrs, Julie Markham, Jacky Talmet, Sandy Dunn, Amanda Mitchell, Lauren Bright, May Lee, Alcohol Services, Bronwyn Gordon, Blair Brewerton, Michael Wallace, Andrew McKinnon, Fionnuala Smyth, Lisa Snell, Elizabeth Laing, Martin Clark, Justin Dorigo, Louise Carman, Toni Hamilton, Ching Tan, Deidre O'Shea, Brent Fergusson, Bonny Puszka, Gai Duncan, Fiona Baker, Jayde Walsh, Leeann Walsh, Hannah Cook, Natasha Nikolic, Louise Hughes, Julia Bitmead, Dean Wang, Kareen Tait, Sav Gollapally, Cáitleen Moloney, Sarah Ahmed   +161 more
wiley   +1 more source

To smoothie or not to smoothie? A mixed-method approach of nutrition pilot intervention among individuals in opioid agonist treatment. [PDF]

BMC Nutr
Carlsen SL, Furulund E, Arjmand EJ, Fiskaaen KTD, Vold JH, Madebo T, Lid TG, Fadnes LT, ATLAS4LAR and FruktBAR study group.   +8 more
europepmc   +1 more source

Exploring metacognitive function in patients with opioid use disorder: A pilot study

Psychology and Psychotherapy: Theory, Research and Practice, Volume 99, Issue 4, Page 1400-1415, December 2026.
Abstract Objectives Despite recognised cognitive deficits related to substance use, as well as high mortality and treatment attrition rates, metacognition has never been studied in patients with opioid use disorder (OUD) undergoing opioid maintenance treatment (OMT).
John Hanson Högberg, Björn Philips, Jonas Stålheim, Kristina Berglund   +3 more
wiley   +1 more source